Correlational Analysis of Genetic Mutations and Galectin Levels in Breast Cancer Patients
Ella G. Markalunas(Brown University), Anna V. Blenda(University of South Carolina), Michael Shtutman(University of South Carolina), William J. Edenfield(Prisma Health), David H. Arnold(University of South Carolina), Julie Martin(Prisma Health), Avery Funkhouser(National Institutes of Health)
Cited by 2
Related Papers
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors
|Journal for ImmunoTherapy of Cancer|2020|117
Increased Circulating Levels of Galectin Proteins in Patients with Breast, Colon, and Lung Cancer
|Cancers|2021|36
Evaluation of BCL6 and SIRT1 as Non-Invasive Diagnostic Markers of Endometriosis
|Current Issues in Molecular Biology|2021|33